Diabetic Nephropathy

Overview

4.6 out of 5 (59 Reviews)

Credits

1.50

Pharmacology Credits

0.5

Post Assessment Questions

9

Start Date

1 Sep 2023

Last Review Date

9 Jan 2025

Expiration Date

31 Aug 2026

Estimated Time To Finish

90 Minutes


Unlimited Nurse Practitioner CE

Stay up to date on the latest medical knowledge with 6811 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 8094.5 hours of CE.

Single Activity

Take this single activity

$73.50 1 activity

6 Month Unlimited Nurse Practitioner CE

Access to all the Unlimited Nurse Practitioner CE activities in all specialties.

$299 per half year per user

1 Year Unlimited Nurse Practitioner CE

Access to all the Unlimited Nurse Practitioner CE activities in all specialties.

$479 per 1 year per user
 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Diabetic nephropathy is the leading cause of end-stage renal disease in developed countries, including the United States. As a microvascular complication, it affects individuals with both type 1 and type 2 diabetes. Significant progress has been made in recent years in understanding the mechanisms of diabetes mellitus, and recent studies have led to updates in treatment guidelines. Staying informed about these latest developments is crucial for providing optimal care to patients with diabetes and kidney disease. The primary pathological features of diabetic kidney disease (DKD) include glomerular hypertrophy, glomerular basement membrane thickening, effacement of podocyte foot processes, and mesangial matrix expansion. Traditional markers of DKD, such as albuminuria and creatinine, are relatively insensitive and have limited utility due to delayed detection.

Several new medication classes have improved the prognosis for patients with diabetes mellitus, with supporting data highlighting their benefits. Lifestyle factors, particularly dietary choices, also play a significant role in the progression of kidney disease and should be carefully evaluated. Early detection and treatment are critical to delaying progression. Diagnosis involves albuminuria assessment, with thresholds for moderate and severe stages. Management emphasizes cardiovascular risk reduction, glycemic and blood pressure control, and renin-angiotensin system inhibition. Recent advances include improved treatment guidelines, novel biomarkers, and a focus on tubulointerstitial injury. This activity explores the causes, pathophysiology, and treatment of diabetic nephropathy, emphasizing recent advancements in therapeutic approaches and lifestyle modifications to improve patient outcomes. This activity also underscores the critical role of the interprofessional healthcare team in optimizing care through coordinated management strategies.


Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the early signs and risk factors of diabetic nephropathy in patients with type 1 and type 2 diabetes.

  • Implement evidence-based management strategies for diabetic nephropathy, including glycemic control, blood pressure management, and cardiovascular risk reduction.

  • Select appropriate biomarkers for monitoring disease progression and assessing treatment efficacy in patients with diabetic nephropathy.

  • Collaborate with interdisciplinary healthcare teams, including nephrologists, dietitians, and cardiologists, to provide comprehensive care for patients with diabetic nephropathy.

  • Outline the pharmacologic therapy as it applies to Diabetic Nephropathy

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Nurse Practitioners: StatPearls designates this activity for 1.50 ANCC contact hour(s), which includes 0.5 hour(s) of pharmacology. NPs should only claim credit commensurate with the extent of their participation in the activity.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

Henrik H. on 4/9/2021

Halyna H. on 9/15/2021

ANWAR S. on 11/17/2021

Hardy M. on 1/28/2022

Charity L. on 4/4/2022

Gary M. on 7/31/2022

Jamin S. on 8/3/2022

Susan G. on 9/15/2022

Toni-Marie P. on 10/19/2022

mandeep s. on 11/9/2022

nancy h. on 12/16/2022

Melissa D. on 12/30/2022

John P. on 3/15/2023

Przemyslaw L. on 3/17/2023

Ok K. on 3/25/2023

Noel J. on 5/17/2023

Rebecca L. on 5/29/2023

Arelly J. on 5/29/2023

Rose B. on 7/21/2023

Milton H. on 8/20/2023

Richard R. on 8/20/2023

Mahmud M. on 9/25/2023

Kathleen on 9/26/2023

Marie Joan Reina W. on 9/29/2023

Jayma C. on 10/10/2023

A M. on 11/8/2023

Casandra R. on 12/5/2023

Jiyoung S. on 12/13/2023

Katelyn J. on 12/15/2023

DHANARAJA PADUBIDRI D. on 12/26/2023

nduka-obi o. on 12/27/2023

madhavi a. on 12/31/2023

Julie A. on 1/14/2024

Man L. on 1/28/2024

Alice F. on 3/4/2024

Derrick R. on 3/7/2024

Samuel O. on 3/8/2024

Mohamad K. on 3/17/2024

SHAIKHA M. on 3/22/2024

Mary M. on 3/28/2024

michael a. on 4/4/2024

Fernando M. on 4/7/2024

DAISY T. on 4/17/2024

Mamta B. on 6/16/2024

Ronda H. on 8/3/2024

Sherilyn F. on 7/27/2024

Regina C. on 9/22/2024

Gautam P. on 9/30/2024

Justine R. on 10/15/2024

April D. on 10/16/2024

Jennifer W. on 11/2/2024

Dr Prashasti k. on 11/3/2024

Jeanne W. on 12/15/2024

Mirim L. on 12/21/2024

Karen H. on 12/23/2024

Diana E. on 12/30/2024

Manuel M. on 1/6/2025

Ehsan q. on 1/9/2025

Fiorella Z. on 1/12/2025

Unlimited Nurse Practitioner CE

Stay up to date on the latest medical knowledge with 6811 CE activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 8094.5 hours of CE.

Single Activity

Take this single activity

$73.50 1 activity

6 Month Unlimited Nurse Practitioner CE

Access to all the Unlimited Nurse Practitioner CE activities in all specialties.

$299 per half year per user

1 Year Unlimited Nurse Practitioner CE

Access to all the Unlimited Nurse Practitioner CE activities in all specialties.

$479 per 1 year per user